Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 58.05% |
| 2 | Technology | 7.69% |
| 3 | Financials | 6.83% |
| 4 | Healthcare | 6.42% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EPZM
3776
DELISTED
Epizyme, Inc
EPZM
| $2.16M | ﹤0.01% |
421,932
-286,928
| -40% | -$1.74M |
|
3777
Compañía de Minas Buenaventura
BVN
$8.92B
| $2.16M | ﹤0.01% |
318,909
-360,336
| -53% | -$2.78M |
|
|
CFFEU
3778
DELISTED
CF Acquisition Corp. VIII Unit
CFFEU
| $2.16M | ﹤0.01% |
212,595
| – | – |
|
3779
CALL
Merit Medical Systems
MMSI
$5.4B
| $2.15M | ﹤0.01% |
+30,000
| New | +$2.04M |
|
|
TRST
3780
Trustco Bank Corp NY
TRST
$973M
| $2.15M | ﹤0.01% |
67,373
+30,923
| +85% | +$1.01M |
|
3781
iShares MSCI India ETF
INDA
$6.61B
| $2.15M | ﹤0.01% |
44,207
+12,681
| +40% | +$591K |
|
3782
Boxlight
BOXL
$4.37M
| $2.15M | ﹤0.01% |
+664
| New | +$2.13M |
|
3783
Sanmina
SANM
$10.4B
| $2.15M | ﹤0.01% |
55,809
-20,262
| -27% | -$777K |
|
|
SRRA
3784
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $2.15M | ﹤0.01% |
98,131
-8,003
| -8% | -$160K |
|
|
BNFT
3785
DELISTED
Benefitfocus, Inc.
BNFT
| $2.15M | ﹤0.01% |
193,490
+94,732
| +96% | +$1.15M |
|
|
MAXN
3786
DELISTED
Maxeon Solar Technologies
MAXN
| $2.15M | ﹤0.01% |
1,217
+1,022
| +524% | +$1.75M |
|
3787
First Financial Corp
THFF
$942M
| $2.15M | ﹤0.01% |
51,001
-12,687
| -20% | -$509K |
|
3788
Sixth Street Specialty
TSLX
$1.79B
| $2.14M | ﹤0.01% |
96,528
-175,306
| -64% | -$4.02M |
|
|
FITB
3789
CALL
Fifth Third Bancorp
FITB
$49.5B
| $2.14M | ﹤0.01% |
50,500
+27,900
| +123% | +$1.07M |
|
|
BNT
3790
Brookfield Wealth Solutions
BNT
$12.3B
| $2.14M | ﹤0.01% |
+57,690
| New | +$2.17M |
|
3791
PUT
TAL Education Group
TAL
$6.62B
| $2.13M | ﹤0.01% |
440,000
-50,000
| -10% | -$444K |
|
|
QTEK
3792
DELISTED
QualTek Services Inc. Class A Common Stock
QTEK
| $2.13M | ﹤0.01% |
214,270
+60,362
| +39% | +$597K |
|
|
CGC
3793
Canopy Growth
CGC
$449M
| $2.13M | ﹤0.01% |
15,339
+13,080
| +579% | +$2.34M |
|
3794
Dentsply Sirona
XRAY
$2.22B
| $2.12M | ﹤0.01% |
36,568
-1,330,931
| -97% | -$82M |
|
|
FARM
3795
DELISTED
Farmer Brothers
FARM
| $2.12M | ﹤0.01% |
252,151
-22,643
| -8% | -$208K |
|
|
ACC
3796
DELISTED
American Campus Communities, Inc.
ACC
| $2.12M | ﹤0.01% |
43,756
-699,507
| -94% | -$34.7M |
|
3797
Adient
ADNT
$1.47B
| $2.12M | ﹤0.01% |
51,046
-223,889
| -81% | -$8.92M |
|
3798
Hayward Holdings
HAYW
$3B
| $2.11M | ﹤0.01% |
+95,048
| New | +$2.14M |
|
|
SPTK
3799
DELISTED
SportsTek Acquisition Corp. Class A Common Stock
SPTK
| $2.11M | ﹤0.01% |
216,769
+125,189
| +137% | +$1.21M |
|
3800
The GEO Group
GEO
$4.25B
| $2.11M | ﹤0.01% |
282,698
-941,660
| -77% | -$6.92M |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander's Q3 2021 filing shows 1,245 new, 2,719 increased, 2,446 reduced and 981 closed positions. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M. The largest sale was Alexion Pharmaceuticals, an estimated $887M.
By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 55% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.